Early Access — free while we kick the tires
EdgarHawk

Gold Kelly

Chief Financial Officer

Officer
1 filing analyzed · 1 company · Latest 2025-09-11

Companies

Company Buys Sells Direction
Camp4 Therapeutics Corp CAMP 1 0 Net buying

Activity

September 2025
high
Buy
6,060 shares
$9,999
Significance 7/10

CFO Gold Kelly buys 6.1K shares at $1.65; 6 other insiders also bought within 14 days as stock trades 76.3% below 52-week high.

Gold Kelly purchased 6,060 shares at $1.65 on 2025-09-11, increasing his holdings by 9.8% to 67.9K shares total. The transaction coincides with a broader insider acquisition pattern: 6 other insiders also bought within the past 14 days, forming a cluster buy signal at a moment when CAMP trades $2.78—down 76.3% from its 52-week high of $11.74 yet up 101.4% over the prior 30 days. The company remains unprofitable with a $-12.6M net loss over its most recent full fiscal year, though it posted strong 86.3% annual revenue growth to $1.5M (latest quarter). The convergence of multiple insider purchases during a period of elevated volatility and significant valuation compression, combined with the company's pre-profitability status, warrants investor attention to the underlying catalysts driving coordinated insider accumulation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access